AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Insulin Glulisine in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Apidra 100 IU/mL Solution for Injection in a Vial** Solution for injection | A6-0366 | Sanofi-Aventis Nigeria Limited | active | 17 Dec 2027 |
Insulin Glulisine — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Insulin Glulisine, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Insulin Glulisine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.